Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
-
SciScore for 10.1101/2020.07.22.202275: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Data matrices were obtained from processed data series downloaded from the NCBI Gene Expression Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/) or Array Express repository Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, RRID:SCR_005012)(https://www.ebi.ac.uk/arrayexpress/). https://www.ebi.ac.uk/arrayexpress/suggested: (ArrayExpress, RRID:SCR_002964)Duplicate genes were removed after the first one identified using Microsoft Excel duplicate remover function. Micros…SciScore for 10.1101/2020.07.22.202275: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Data matrices were obtained from processed data series downloaded from the NCBI Gene Expression Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/) or Array Express repository Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, RRID:SCR_005012)(https://www.ebi.ac.uk/arrayexpress/). https://www.ebi.ac.uk/arrayexpress/suggested: (ArrayExpress, RRID:SCR_002964)Duplicate genes were removed after the first one identified using Microsoft Excel duplicate remover function. Microsoft Excelsuggested: (Microsoft Excel, RRID:SCR_016137)Statistical analysis: All module score calculations were calculated in R v3.6.1 and RStudio v1.2.1335, using scripts generated and deposited in our previous publication (https://github.com/MJMurray1/MDIScoring) (Pollara et al., 2017). RStudiosuggested: (RStudio, RRID:SCR_000432)Mann-Whitney tests, Spearman rank correlations and Kruskal-Wallis tests were calculated in GraphPad Prism v8.4. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your code.
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Our study has limitations. Despite drawing on four independent COVID-19 datasets, the sample sizes assessed in our study were still modest, especially for longitudinal samples, but this was limited by the data available. Assessments of the transcriptome from leucocytes and whole blood in COVID-19 may not be interchangeable and will need cross-validating, although both datasets demonstrated no association between IL-1β or IL-6 activity and severity of disease. Determining the sensitivity and specificity of the IL-1β and IL-6 response modules for their respective cognate cytokines was limited by the available datasets and the range of cytokine stimulation conditions performed in those experiments. Comparing the expression of these modules across a wider range of biologically paired cytokine stimulations will allow refinement of their accuracy. As the modules were generated from in vitro experiments, we sought to determine their applicability in vivo, assessing neutralisation of cytokine activity following immunomodulation with biologic agents in vivo. IL-1β activity in blood and in tissues was diminished days after canakinumab (fig 3) and anakinra (Pollara et al., 2019) administration respectively, but no equivalent datasets were available to assess the IL-6 response module in the same manner. Biobanked samples from ongoing tocilizumab clinical trials in COVID-19 and other diseases may provide an opportunity to validate IL-6 module performance in this way. In conclusion, our da...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-